What does the evidence say about Fiber Cholesterol Randomized Trial?

The current Migaku evidence database contains 1 reusable source document for Fiber Cholesterol Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Saskatoon berry (SB), a traditional food of Indigenous people, has been associated with cardiometabolic benefits in animal models; however, its effects on humans remain unclear. [Lee E (2026); evidence level 4] - SB intake significantly reduced fasting plasma glucose, total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-c), non-high-density lipoprotein-cholesterol (non-HDL-c), systolic blood pressure, and high-sensitivity C-reactive protein, while increasing dietary fiber intake. [Lee E (2026); evidence level 4] - Fiber intake was negatively correlated with TC, LDL-c and non-HDL-c ( p p < 0.05-0.0001), while being negatively associated with lipid profiles and blood pressure. [Lee E (2026); evidence level 4] - This study investigated the effects of dried SB consumption on cardiometabolic outcomes, gut microbiota, and short-chain fatty acids (SCFAs) profiles in healthy adults. [Lee E (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.